![Douglas Love](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Love
Directeur Général chez
ANNEXON, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Douglas Love is President, Chief Executive Officer & Director at Annexon, Inc. since 2014.
Formerly, Mr. Love was Corporate Counsel at Amgen, Inc. from 1999 to 2001, Corporate Counsel at Genentech, Inc. from 2001 to 2006, Head-Operations & Strategic Alliances at Elan Pharmaceuticals LLC from 2008 to 2013, and Associate at Orrick Herrington & Sutcliffe LLP from 1996 to 1999.
Education includes an undergraduate degree from the University of Southern California in 1991 and a graduate degree from McGeorge School of Law in 1995.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ANNEXON, INC. 0,22 % | 31/03/2026 | 356 133 ( 0,22 % ) | 2 M $ | 31/05/2026 |
Postes actifs de Douglas Love
| Sociétés | Poste | Début |
|---|---|---|
| ANNEXON, INC. | Directeur Général | 01/12/2014 |
Anciens postes connus de Douglas Love
| Sociétés | Poste | Fin |
|---|---|---|
Elan Pharmaceuticals LLC
 Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | 01/04/2013 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Conseiller Juridique Général | 01/01/2006 |
| AMGEN INC. | Conseiller Juridique Général | 01/01/2001 |
Orrick Herrington & Sutcliffe LLP
 Orrick Herrington & Sutcliffe LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm in technology, innovation, finance, energy and infrastructure sectors | Corporate Officer/Principal | 01/01/1999 |
Formation de Douglas Love
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Elan Pharmaceuticals LLC
Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orrick Herrington & Sutcliffe LLP
Orrick Herrington & Sutcliffe LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm in technology, innovation, finance, energy and infrastructure sectors | Commercial Services |
Mcgeorge School of Law
 Mcgeorge School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
